A detailed history of Gabelli Funds LLC transactions in Haleon PLC stock. As of the latest transaction made, Gabelli Funds LLC holds 13,000 shares of HLN stock, worth $126,099. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,000
Previous 17,000 23.53%
Holding current value
$126,099
Previous $140,000 2.14%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$8.32 - $10.7 $33,280 - $42,800
-4,000 Reduced 23.53%
13,000 $137,000
Q3 2023

Nov 08, 2023

BUY
$7.85 - $8.94 $23,550 - $26,820
3,000 Added 21.43%
17,000 $141,000
Q2 2023

Aug 10, 2023

SELL
$8.04 - $9.0 $24,119 - $27,000
-3,000 Reduced 17.65%
14,000 $117,000
Q1 2023

May 12, 2023

SELL
$7.57 - $8.37 $757 - $836
-100 Reduced 0.58%
17,000 $138,000
Q4 2022

Feb 13, 2023

SELL
$5.96 - $8.06 $6,556 - $8,866
-1,100 Reduced 6.04%
17,100 $136,000
Q3 2022

Nov 10, 2022

BUY
$5.63 - $7.5 $102,466 - $136,500
18,200 New
18,200 $111,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.